OtisMed

OtisMed was a medical technology company that specialized in patient-specific surgical instrumentation for orthopedic procedures. The company's primary product, the OtisKnee, utilized pre-operative MRI scans and proprietary software to create custom-fit cutting guides for total knee arthroplasty, aiming to improve implant alignment and surgical precision. In November 2009, OtisMed was acquired by Stryker Corporation for approximately $100 million to bolster its reconstructive surgery portfolio. However, the company later became the subject of a major legal case after it was revealed that it had marketed the OtisKnee device without obtaining the necessary FDA clearance. This resulted in significant criminal and civil penalties for the company and its leadership, including an $80 million settlement. Despite the legal controversy, the company's technology contributed to the development of personalized surgical solutions in the orthopedics industry.